Douglas MurphyChutorian - Semler Scientific President CEO, Director
SMLR Stock | USD 27.09 0.83 3.16% |
CEO
Dr. Douglas MurphyChutorian, M.D. is a President, Chief Executive Officer, Director of Semler Scientific, Inc. He has served as a member of our board of directors since September 2012 and as our chief executive officer since October 31, 2012. Dr. MurphyChutorian has had broad, diverse career experience in healthcare over the past 30 years, stretching from clinician, academician, inventor, entrepreneur, chief executive officer, chairman of the board, and consultant to financial firms. Since April 15, 2005, he was managing director of Select Healthcare Capital, LLC. Dr. MurphyChutorian is a named inventor on more than 30 patents, and has guided more than 50 products through various regulatory approval processes. His business career has included extensive involvement in all facets of the medical industry from financial, research and development, manufacturing, marketing and sales, regulatory, reimbursement, and clinical trials. His breadth of healthcare experience includes all major sectors of the industry medical devices, health services, pharmaceuticals, biotechnology and managed care. He received his B.A. and M.D. from Columbia University. He completed his internal medicine residency at New York UniversityBellevue Medical Center and his fellowship in cardiology at Stanford University Medical Center. He has served as a faculty member in interventional cardiology at both Stanford and Montefiore Medical Center. Dr. MurphyChutorians experience as a cardiologist, inventor and executive, in particular serving as our Chief Executive Officer, qualify him to be a director of our company. since 2016.
Age | 62 |
Tenure | 8 years |
Address | 2340-2348 Walsh Avenue, Santa Clara, CA, United States, 95051 |
Phone | (877) 774-4211 |
Web | https://www.semlerscientific.com |
Semler Scientific Management Efficiency
The company has return on total asset (ROA) of 0.2042 % which means that it generated a profit of $0.2042 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.3229 %, meaning that it created $0.3229 on every $100 dollars invested by stockholders. Semler Scientific's management efficiency ratios could be used to measure how well Semler Scientific manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Semler Scientific's Return On Tangible Assets are relatively stable compared to the past year. As of 04/24/2024, Return On Assets is likely to grow to 0.28, while Return On Capital Employed is likely to drop 0.29. At this time, Semler Scientific's Intangibles To Total Assets are relatively stable compared to the past year. As of 04/24/2024, Fixed Asset Turnover is likely to grow to 23.82, while Other Assets are likely to drop 0.95.Similar Executives
Found 4 records | CEO Age | ||
Jon Kessler | HealthEquity | 56 | |
Michael Hays | National Research Corp | 69 | |
Oivind Horpestad | National Research Corp | N/A | |
Lennart Flem | National Research Corp | N/A |
Management Performance
Semler Scientific Leadership Team
Elected by the shareholders, the Semler Scientific's board of directors comprises two types of representatives: Semler Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Semler. The board's role is to monitor Semler Scientific's management team and ensure that shareholders' interests are well served. Semler Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Semler Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
Dennis Rosenberg, Chief Officer | ||
Aidan Collins, Director | ||
Arthur Leibowitz, Director | ||
Chutorian Murphy, CEO, Director | ||
Herbert Semler, Chairman of the Board, Co-Founder | ||
Andrew Weinstein, Principal Financial Officer, Senior Vice President - Finance and Accounting | ||
James Walker, CFO | ||
Douglas MD, President CEO | ||
Cindy Guinasso, Senior Development | ||
Robert McRae, Chief Officer | ||
Bruce Barclay, Director | ||
Jennifer Herrington, Chief Officer | ||
Shirley Semler, Co-Founder, Director | ||
Douglas MurphyChutorian, President CEO, Director | ||
Shane Reid, Chief Officer | ||
Wayne Pan, Director | ||
Greg Garfield, Director | ||
Daniel Conger, VP of Fin. | ||
Renae Cormier, Principal CFO |
Semler Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Semler Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.32 | ||||
Return On Asset | 0.2 | ||||
Profit Margin | 0.30 % | ||||
Operating Margin | 0.18 % | ||||
Current Valuation | 127.6 M | ||||
Shares Outstanding | 7.03 M | ||||
Shares Owned By Insiders | 22.22 % | ||||
Shares Owned By Institutions | 52.35 % | ||||
Number Of Shares Shorted | 216.4 K | ||||
Price To Earning | 16.64 X |
Currently Active Assets on Macroaxis
When determining whether Semler Scientific is a strong investment it is important to analyze Semler Scientific's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Semler Scientific's future performance. For an informed investment choice regarding Semler Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Semler Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. To learn how to invest in Semler Stock, please use our How to Invest in Semler Scientific guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Semler Stock analysis
When running Semler Scientific's price analysis, check to measure Semler Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Semler Scientific is operating at the current time. Most of Semler Scientific's value examination focuses on studying past and present price action to predict the probability of Semler Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Semler Scientific's price. Additionally, you may evaluate how the addition of Semler Scientific to your portfolios can decrease your overall portfolio volatility.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Transaction History View history of all your transactions and understand their impact on performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Semler Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Semler Scientific. If investors know Semler will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Semler Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.315 | Earnings Share 2.63 | Revenue Per Share 10.127 | Quarterly Revenue Growth 0.091 | Return On Assets 0.2042 |
The market value of Semler Scientific is measured differently than its book value, which is the value of Semler that is recorded on the company's balance sheet. Investors also form their own opinion of Semler Scientific's value that differs from its market value or its book value, called intrinsic value, which is Semler Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Semler Scientific's market value can be influenced by many factors that don't directly affect Semler Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Semler Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Semler Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Semler Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.